Who this is for
This page is for people who have spent time in a damp building and now feel unwell, or who were handed a urine mycotoxin printout and a binder, sauna, or antifungal package. It is also for parents and clinicians who need a clear split between real building-related illness and an unvalidated detox story.
Indoor dampness is a legitimate public-health issue. CDC materials on mold and damp buildings describe respiratory and allergic problems, including worse asthma in susceptible people. NIEHS likewise treats mold as a common indoor exposure that can irritate airways. Those facts do not mean every symptom is systemic mycotoxin poisoning, and they do not validate a cash-pay urine panel.
This is not written for people in acute respiratory distress, and it is not a protocol to stay in a flooded home. Severe shortness of breath, low oxygen, coughing blood, or fever in someone with a weak immune system needs urgent medical care. It is also not a ranking of mold-detox clinics. Licensed decisions stay with physicians, nurse practitioners, physician assistants, and, when needed, pulmonology, allergy, infectious disease, or occupational medicine.
People with known asthma, allergic rhinitis, or hypersensitivity pneumonitis already have condition-specific care paths. A longevity menu should not replace inhalers, allergen control, or workplace evaluation. If your main problem is visible mold and a musty building, the first job is moisture control, not a supplement stack.
What options clinics actually offer
Some clinics do ordinary medicine: history, exam, spirometry or peak flow when asthma is suspected, and advice to fix leaks. That is appropriate. Others sell a mold-illness identity built on direct-to-consumer urine mycotoxin tests, then offer cholestyramine or other binders, antifungals, glutathione, ozone, sauna, or restrictive diets.
CDC’s 2015 MMWR note is the key regulatory fact. There is no FDA-approved test for mycotoxins in human urine. The lab CDC reviewed advertised CLIA certification, which covers laboratory operations, not whether the result diagnoses disease. Mycotoxins appear in urine of healthy people because low levels occur in many foods. Levels that predict illness have not been established.
Binder protocols are often the next sale. A binder is a substance meant to grab something in the gut. Prescription binding resins exist for labeled lipid or bile-acid uses. Using them as a mold detox because a urine kit was positive is not that labeled care. Antifungals for indoor exposure without a documented invasive infection are another common extra. Those drugs have real toxicities.
Environmental sampling packages can be useful to a remediator in selected cases. CDC has said visual inspection and moisture control matter more than routine biologic testing of occupants. A clinic that treats a spore count or a urine graph as a prescription is mixing building science with an unvalidated medical test.
What evidence supports
Evidence supports a link between damp indoor spaces and respiratory symptoms, including asthma exacerbation. That is why public-health advice starts with finding water, drying materials, and cleaning or removing moldy surfaces with methods matched to the job size. People with asthma should keep using their action plan while the building is fixed.
Evidence does not support urine mycotoxin testing as a clinical diagnosis of building-related illness. CDC stated that those tests are unvalidated, that FDA has not approved them for that use, and that CDC does not recommend biologic testing of people who live or work in water-damaged buildings as a routine step. A positive commercial result therefore cannot justify a disease label or a detox course.
Foodborne mycotoxins are a separate, real topic. NIEHS notes aflatoxin on some crops as a known hazard when ingested. That is an agricultural and food-safety problem. It is not proof that a home bathroom leak created a blood toxin burden you can wash out with charcoal or clay.
NCCIH’s consumer page on detoxes and cleanses is useful here even though it is broader than mold. Commercial cleanses often lack evidence they remove toxins and can be unsafe or falsely advertised. Binder stacks, saunas, and IVs sold after an unvalidated test sit in that same weakly supported category.
- Supported: moisture repair, safer cleanup, asthma and allergy care, specialist evaluation when indicated.
- Not supported: diagnosing illness from a commercial urine mycotoxin kit.
- High risk: antifungals, binders, or restrictive protocols without a validated diagnosis.
When to see a clinician first
See a licensed clinician for breathing changes, wheeze, chest tightness, recurrent sinus symptoms, or cough that tracks with a damp building. Bring the timeline: leak, flood, musty odor, and when symptoms start or ease away from the building. That history is more useful than a toxin score.
Go urgently for severe dyspnea, bluish lips, confusion, coughing blood, high fever, or symptoms in a transplant patient, a person on strong immunosuppressants, or someone with poorly controlled asthma. Invasive fungal disease is uncommon in healthy people and is not treated with a wellness cleanse.
Ask for pulmonary, allergy, or occupational medicine when symptoms persist after the building is dry, or when work exposures include compost, grain, or industrial moisture. Hypersensitivity pneumonitis and occupational asthma are specialty diagnoses. Do not let a binder protocol delay those referrals.
If you already started a clinic antifungal or resin, tell every clinician and pharmacist. Drug interactions and liver injury are reasons to review the list, not to add another detox product. Children and pregnant people need pediatric or obstetric input before any of these agents.
How to judge progress
Progress is a drier building and a clearer medical plan, not a falling mycotoxin number on an unvalidated test. If asthma was the problem, judge rescue-inhaler use, night symptoms, and peak flows your clinician already tracks. If the building still smells musty, the medical add-ons are not the main lever.
Recheck with the same licensed clinician after remediation, not with a second urine kit used to sell another month of binders. Ask what diagnosis you actually have in medical language. Toxic mold illness on a brochure is not a substitute for asthma, rhinitis, infection, or another named condition.
Stop and reassess if a protocol causes constipation that blocks other medicines, new jaundice, severe fatigue, or worse breathing. Those are adverse effects or a missed diagnosis. Walk away from guaranteed detox, from CLIA-as-proof claims, and from clinics that will not discuss CDC’s warning about urine mycotoxin tests.
You can take building moisture seriously and still refuse an unvalidated test-and-binder funnel. Licensed care treats the condition you have. Public-health care treats the water. Neither requires a commercial mycotoxin cleanse.
Frequently Asked Questions
References
CDC MMWR: Unvalidated Urine Mycotoxin Tests for Clinical Diagnosis
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6406a7.htmCDC: Health Problems Associated With Dampness and Mold
https://www.cdc.gov/mold-health/about/index.htmlNCCIH: Detoxes and Cleanses — What You Need to Know
https://www.nccih.nih.gov/health/detoxes-and-cleanses-what-you-need-to-know
Your Privacy Choices